ASX:ME1 Melodiol Global Health (ME1) Stock Price, News & Analysis → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free ME1 Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisInsider TradesStock AnalysisInsider Trades Get Melodiol Global Health alerts: Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Melodiol Global HealthMelodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.Read More Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ME1 Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive ME1 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Melodiol Global Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:ME1 CUSIPN/A CIKN/A Webmelodiolglobalhealth.com Phone61-8-9389-3180FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-35,520,000.00 Net Margins-277.18% Pretax MarginN/A Return on Equity-389.56% Return on Assets-33.31% Debt Debt-to-Equity Ratio120.82 Current Ratio0.24 Quick RatioN/A Sales & Book Value Annual Sales$18.92 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA($0.02) per share Price / BookN/AMiscellaneous Outstanding Shares281,870,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta2.56 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Boaz Wachtel M.A. (Age 63)M.D., MBA, Co-Founder & Non-Executive Chairman Comp: $80kMr. William Lay B.Com.Group CEO, MD & DirectorMr. Christopher Grundy BComFCA, FCIS, GAICD, Chief Financial OfficerMs. Micheline MacKay B.Sc.M.Sc., P.M.P., Executive DirectorDr. Gian TreppCommercial & Marketing DirectorMr. Mitchel FlemingManaging Director of HalucenexBrett AyersManaging Director of ImpactiveMr. Winton William Willesee C.P.A. (Age 54)GAICD, MAICD, MCom, Joint Company Secretary Hon. Brian WalkerStrategic Consultant & Chair of Scientific Advisory CommitteeMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All CompetitorsInsidersBruce LintonSold 10,000,000 sharesTotal: $10,000.00 ($0.00/share)Jodi ScottSold 44,972,436 sharesTotal: $269,834.62 ($0.01/share)William LaySold 5,000,000 sharesTotal: $15,000.00 ($0.00/share)William LaySold 5,000,000 sharesTotal: $35,000.00 ($0.01/share)William LaySold 10,000,000 sharesTotal: $70,000.00 ($0.01/share)View All Insider Transactions This page (ASX:ME1) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe 1,000X Crypto PlaybookTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityThe #1 Crypto for AIWeiss RatingsWhy Is Gold On a MASSIVE rally? Huge AlertsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Melodiol Global Health Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
